Compounded Dermatology Medications for Provider-Directed Skin and Scalp Care
MediVera Compounding Pharmacy is a PCAB-accredited dermatology compounding pharmacy that works with licensed providers to prepare prescription-based skin and scalp formulations. When a care plan calls for a formulation that commercially available products do not supply – a specific concentration, combination of actives, or delivery vehicle – MediVera prepares that compound to the exact prescription written by the provider.
Every medication MediVera prepares for dermatology starts with a provider’s order. MediVera does not diagnose conditions or recommend treatments. It dispenses dermatology compounds only after receiving a valid prescription. MediVera’s PCAB accreditation includes sterile and non-sterile compounding. The pharmacy also uses independent third-party testing as part of its quality program. Review MediVera’s quality and compliance standards before prescribing.
Dermatology Compound Categories
Licensed providers prescribe to MediVera across the following dermatology compound categories:
- Pigmentation support formulations – hydroquinone creams, tranexamic acid combinations, azelaic acid formulas, and multi-ingredient pigmentation protocols for provider-directed care
- Skin support formulations – redness support creams, facial formulations with CoQ10, Vitamin C ester, and estriol, and other provider-directed skin health preparations
- Skin texture formulations – tretinoin-based preparations and aloe vera combinations for skin texture and elasticity support as directed by prescribing providers
- Low Dose Naltrexone (LDN) capsules – available in 1.5mg, 3mg, and 4.5mg for provider-directed immune system support protocols in dermatology
All compounds require a valid prescription from a licensed provider. Compounded medications are not reviewed by the FDA for safety or effectiveness. Browse the full compounding services overview for additional therapeutic categories.
Providers can prescribe by:
If you have any further questions, contact us at [email protected]